Literature DB >> 12684966

Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats.

Tatsuo Shirota1, Mie Tashiro, Kohsuke Ohno, Akira Yamaguchi.   

Abstract

PURPOSE: This study investigated the effect of parathyroid hormone (1-34) [PTH(1-34)] on bone reactions after tibial placement of titanium screw implants into ovariectomized rats.
MATERIALS AND METHODS: Twelve-week-old female Wistar rats were divided into 3 groups of 24. The first group (Sham group) was sham-operated; the second group (OVX group) was ovariectomized only; and the third group (PTH group) was subcutaneously administered 30 microg/kg PTH in the dorsal region 3 days per week starting the fourth week after ovariectomy until the end of the experiment. Titanium screw implants were placed in the proximal metaphysis of the tibia of all 3 groups at 168 days after surgery. The animals were killed 7, 14, 28, and 56 days after implantation. Undecalcified sections were prepared and evaluated by light microscopy. Histomorphometric measurements were obtained using a computer-based image analyzer to quantify the unit bone mass around the implant and the rate of implant-bone contact.
RESULTS: When PTH administration was started 21 days after ovariectomy, the volume density of bone around implants in the PTH group was almost the same as that of the Sham group throughout the entire observation period. This finding suggests that not only can intermittent human PTH(1-34) administration prevent resorption of newly generated trabeculae around an implant but also it can aid in the recovery of bone volume lost due to ovariectomy.
CONCLUSION: When dental implants are applied to jaw bone showing trabecular bone loss, it may be possible to increase bone density around an implant by intermittent human PTH(1-34) administration and thereby improve clinical results. Copyright 2003 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 61:471-480, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684966     DOI: 10.1053/joms.2003.50093

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  19 in total

Review 1.  Efficacy of parathyroid hormone supplementation on the osseointegration of implants: a systematic review.

Authors:  Fawad Javed; Mohammad D Al Amri; Sergio Varela Kellesarian; Abdulaziz A Al-Kheraif; Fahim Vohra; José Luis Calvo-Guirado; Hans Malmstrom; Georgios E Romanos
Journal:  Clin Oral Investig       Date:  2015-12-22       Impact factor: 3.573

2.  The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs.

Authors:  Zhou-Shan Tao; Wan-Shu Zhou; Bing-li Bai; Wei Cui; Yang-Xun Lv; Xian-Bin Yu; Zheng-Liang Huang; Kai-kai Tu; Qiang Zhou; Tao Sun; Hang Li; Lei Yang
Journal:  J Mater Sci Mater Med       Date:  2016-01-12       Impact factor: 3.896

3.  Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface.

Authors:  Y F Li; X D Li; C Y Bao; Q M Chen; H Zhang; J Hu
Journal:  Osteoporos Int       Date:  2013-01-08       Impact factor: 4.507

4.  Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.

Authors:  Hang Li; Qiang Zhou; Bing-Li Bai; She-Ji Weng; Zong-Yi Wu; Zhong-Jie Xie; Zhen-Hua Feng; Liang Cheng; Viraj Boodhun; Lei Yang
Journal:  J Bone Miner Metab       Date:  2017-12-26       Impact factor: 2.626

5.  The combined effect of parathyroid hormone and bone graft on implant fixation.

Authors:  H Daugaard; B Elmengaard; T T Andreassen; J Baas; J E Bechtold; K Soballe
Journal:  J Bone Joint Surg Br       Date:  2011-01

Review 6.  Effects of anti-osteoporosis medications on fracture healing.

Authors:  Niklas R Jørgensen; Peter Schwarz
Journal:  Curr Osteoporos Rep       Date:  2011-09       Impact factor: 5.096

7.  PTH 1-84: bone rebuilding as a target for the therapy of severe osteoporosis.

Authors:  Fabio Vescini; Franco Grimaldi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

8.  Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.

Authors:  B Chen; Y Li; X Yang; H Xu; D Xie
Journal:  Osteoporos Int       Date:  2013-02-07       Impact factor: 4.507

9.  PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet.

Authors:  R Dayer; T C Brennan; R Rizzoli; P Ammann
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

10.  The effects of a nonsteroidal anti-inflammatory drug on the degree of titanium implant osseointegration.

Authors:  Vesile Elif Toy; Serkan Dundar; Alihan Bozoglan
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.